MedWatch

Amplifon lands all-time high revenue, projects positive 2022

In 2021, hearing aid retailer Amplifon has made significant advancements on all its markets, and according to the company’s recently publicized annual report, sales in the first two months of 2022 indicate a strong year ahead.

The Covid-19 pandemic seems to have loosened its tight grip on the hearing aid industry, which was sent to its knees in 2020 across the globe.

At least according to the world’s biggest hearing aid retailer, Italian Amplifon, which is a customer of Demant, WSA and GN Hearing. The company has enjoyed a considerable tailwind in 2021, the annual report for 2021 reveals on Friday.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Rumored GN purchase unlikely but not impossible, say analysts

A low value assessment, a high structural value, and no dominant shareholders make GN Group a reasonable investment case for international private equity firms and industrial players. But just how likely is it? Analysts reveal their best bets for what a GN acquisition could look like.

New CFO wants to shake things up at WSA

A mere month into her new job, Marianne Wiinholt, WS Audiology’s fifth chief financial officer since the firm was established through a merger in 2019, is heralding great structural changes.

Further reading

Related articles

Latest news

See all jobs